treatment strategy malignant liver tumors appropriately determined quality life greatly depends patients residual hepatic function report present patients malignant liver tumors treated proton beam therapy hepatic functional reserves evaluated sequentially year human serum albumin scintigraphy patients exhibited distinctive time course uptake efficiency suggested transient decline ratio liver activity heart liver activity NUMBER minutes lhl15 months proton beam therapy change parallel expected functioning normal liver tissue volume year proton beam therapy lhl15 recovered nearly level patients observations related 99mtcgsa uptake hepatic regeneration proton beam therapy references NUMBER post treatment pre post therapeutic 99mtechnetium galactosyl 99mtc gsa 99mtc gsa NUMBER NUMBER pre treatment regulation receptor mediated